Page 1438 - Problem-Based Feline Medicine
P. 1438

INDEX  1431


             urinary tract infection, 226      378, 399–400, 500, 529,        684–685, 811, 844, 907, 911,
             see also specific infections      545–546, 684–685, 726,         1143, 1284, 1296
           Feline herpes virus-1, 365, 370,    749–750, 1302              diagnosis, 352–353, 373, 430–431,
               1333–1341                    concurrent infections, 8          456–457, 546, 685, 811,
             see also Feline herpes virus keratitis;  cranial mediastinal lymphosarcoma  844–845, 911, 1144, 1266,
                Feline rhinotracheitis (feline  and, 115                      1284, 1296
                herpes virus-1)             diagnosis, 341, 378–379, 400, 500,  cerebrospinal fluid analysis,
           Feline herpes virus conjunctivitis,  546, 685, 726, 750, 1302        910
               1212–1215                    diarrhea, acute small bowel, 700,  diarrhea, acute small bowel, 699
             bulbar conjunctiva, red coloration,  726                     diarrhea, chronic small bowel, 749
                1197                        diarrhea, chronic small bowel, 736,  differential diagnosis, 353, 373, 431,
             clinical signs, 1212–1213         749–750                        457–458, 811, 845, 911–912,
             diagnosis, 1213                differential diagnosis, 341, 400, 501  1144
             differential diagnosis, 1213–1214,  epidemiology, 340        effusive (wet) form, 352, 1180
                1216, 1222                  hemorrhage, 483, 500–501        clinical signs, 321
             ocular discharge/changed       hyperplasia, idiopathic atypical and,  diagnosis, 353
                conjunctival appearance, 1208,  413                       encephalitis, 829, 859, 860, 887
                1212–1215                   lymphadenopathy, 395, 399–400  fading kitten/neonate, 1128,
             pathogenesis, 1212             myopathy, 943, 971                1143–1144
             prognosis, 1215                ocular manifestations         fulminant, 749
             third eyelid, 1333–1341         cloudy vitreous, 1257, 1275–1276  granulomas, 719, 749
             transmission, 1215              infection, 1174, 1176        head tilt/vestibular ataxia/nystagmus,
             treatment, 1214–1215            iris abnormality, 1293, 1302     836, 844–845
           Feline herpes virus keratitis,   opportunistic infections, 340, 342  hydrothorax, 73, 81–83
               1229–1230, 1234, 1237–1241,  pathogenesis, 339–340, 399, 500,  jaundice/elevated liver enzymes,
               1259–1260                       1275, 1302                     423, 430–431
             clinical signs, 1219, 1229, 1238,  persistent generalized    lameness, 984
                1255, 1260                     lymphadenopathy, 340       neurological signs, 1180, 1266
             cloudy cornea, 1259–1260       polymyositis from, 960        non-effusive (dry) form, 352, 719,
             corneal abnormality, 1237–1241  prevention, 342                  749, 911, 1180
             corneal sequestrum, 1261       prognosis, 342, 400, 501      ocular manifestations
             diagnosis, 1229–1230, 1239, 1260  pyrexia, 365, 378–379        cloudy anterior chamber, 1256,
             differential diagnosis, 1239, 1242  stages, 340                    1266
             ocular discharge/changed       terminal clinical phase, 340    infection, 1167, 1173–1174, 1176,
                conjunctival appearance, 1210,  thin, inappetent, 339–342       1179–1181, 1188–1189
                1229–1230                   treatment, 341–342, 400, 501    iris abnormality, 1293, 1295–1296
             pathogenesis, 1237–1238        vaccination, 342                pupil abnormality, 1279, 1280,
             prevention, 1241               vomiting, chronic, 665, 684–685     1284
             prognosis, 1240              Feline immunodeficiency virus (FIV)  visual cortex problems, 1169
             transmission, 1240–1241         antibody test, 500           pathogenesis, 372, 456, 844, 1296
             treatment, 1239–1240         Feline immunodeficiency virus (FIV)  prevention, 374, 458, 845
             ulcerative keratitis, 1247      encephalopathy, 798, 819–820  prognosis, 374, 458, 845
           Feline hyperesthesia syndrome see  Feline infectious peritonitis (FIP),  pyrexia, 372–374
               Hyperesthesia syndrome        81–83, 352–353, 365, 372–374,  seizures/circling/changed behavior,
           Feline immunodeficiency virus (FIV),  430–431, 456–458, 545–546,   797, 811–812
               339–342, 378–379, 399–400,    684–685, 718–719, 749, 811–812,  thin, inappetent, 352–353
               500–501, 545–546, 684–685, 726,  844–845, 911–912, 1143–1144,  titers, 353, 373
               749–750, 1275–1276, 1302      1179–1181, 1284, 1295–1296   transmission, 374, 458
             acute, 340                     abdominal distention/fluid, 446,  treatment, 353, 373–374, 458, 812,
             anemia, 545–546                   449–450, 456–458               845, 912, 1144, 1296
             associated conditions, 340–341  anemia, 545–546              vomiting, chronic, 665, 684–685
             asymptomatic carrier phase, 340  clinical signs, 331, 348, 352, 372,  weakness with ataxia/paralysis,
             clinical signs, 331, 339, 340–341,  429, 430, 456, 529, 545–546,  911–912
   1433   1434   1435   1436   1437   1438   1439   1440   1441   1442   1443